Teo L, Seah LL, Choo CT, Chee SP, Chee E, Looi A. A survey of the histopathology of lacrimal gland lesions in a tertiary referral centre. Orbit. 2013;32:1–7.
Andrew NH, McNab AA, Selva D. Review of 268 lacrimal gland biopsies in an Australian cohort. Clin Exp Ophthalmol. 2015;43:5–11.
Luemsamran P, Rootman J, White VA, Nassiri N, Heran MKS. The role of biopsy in lacrimal gland inflammation: a clinicopathologic study. Orbit. 2017;36:411–8.
Chung SR, Kim GJ, Choi YJ, Cho KJ, Suh CH, Kim SC, et al. Clinical and radiological features of diffuse lacrimal gland enlargement: comparisons among various etiologies in 91 biopsy-confirmed patients. Korean J Radio. 2022;23:976–85.
Ginat DT, Freitag SK, Kieff D, Grove A, Fay A, Cunnane M, et al. Radiographic patterns of orbital involvement in IgG4-related disease. Ophthalmic Plast Reconstr Surg. 2013;29:261–6.
Zeppieri M, Patel R & Patel BC. Dacryoadenitis. 2025. https://www.ncbi.nlm.nih.gov/books/NBK535384/.
Tang J, Cai S, Ye C, Dong L. Biomarkers in IgG4-related disease: a systematic review. Semin Arthritis Rheum. 2020;50:354–9.
Karim AF, Eurelings LEM, Bansie RD, van Hagen PM, van Laar JAM, Dik WA. Soluble interleukin-2 receptor: a potential marker for monitoring disease activity in IgG4-related disease. Mediators Inflamm. 2018;2018:6103064.
Choi CJ, Tran AQ, Anagnostopoulos AG, Zhou HW, Tse DT, Dubovy SR. A single-institution review of lacrimal gland biopsies between 1962 and 2017. Orbit. 2023;42:148–56.
von Holstein SL, Therkildsen MH, Prause JU, Stenman G, Siersma VD, Heegaard S. Lacrimal gland lesions in Denmark between 1974 and 2007. Acta Ophthalmol. 2013;91:349–54.
Matsuo T, Tanaka T, Sato Y, Kataoka H, Uka M, Ennishi D, et al. Follow-up with serum IgG4-monitoring in 8 patients with IgG4-related disease diagnosed by a lacrimal gland mass. J Clin Exp Hematop. 2021;61:10–21.
Takahira M, Goto H, Azumi A. The 2023 revised diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol. 2024;68:293–301.
Takahira M, Kawano M, Zen Y, Minato H, Yamada K, Sugiyama K. IgG4-related chronic sclerosing dacryoadenitis. Arch Ophthalmol. 2007;125:1575–8.
Pakdaman MN, Sepahdari AR, Elkhamary SM. Orbital inflammatory disease: pictorial review and differential diagnosis. World J Radio. 2014;6:106–15.
Ishikawa E, Takahashi Y, Valencia MRP, Ana-Magadia MG, Kakizaki H. Asymmetric lacrimal gland enlargement: an indicator for detection of pathological entities other than thyroid eye disease. Graefes Arch Clin Exp Ophthalmol. 2019;257:405–11.
Konno S, Shijubo N, Suda T. Diagnostic standard 2023 and classification of disease severity for sarcoidosis in Japan. Jpn J Sarcoidosis Other Granulomatous Disord. 2024;44:59–63.
Mombaerts I, Bilyk JR, Rose GE, McNab AA, Fay A, Dolman PJ, et al. Consensus on diagnostic criteria of idiopathic orbital inflammation using a modified Delphi approach. JAMA Ophthalmol. 2017;135:769–76.
Yamamoto M, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, Takahashi H, et al. Elevated IgG4 concentrations in serum of patients with Mikulicz’s disease. Scand J Rheumatol. 2004;33:432–3.
Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;385:1460–71.
Priel A, Vishnevskia-Dai V, Hochma L, Gildener-Leapman J, Ben Simon GJ, Rosner M, et al. The epidemiological, clinical and histopathological characteristics of lacrimal gland biopsies in a tertiary care center in Israel. Isr Med Assoc J. 2018;20:104–8.
He L, He W. Clinicopathological features of lacrimal gland biopsy lesions in 582 Chinese patients. Sci Rep. 2024;14:26514.
Ahn C, Kang S, Sa HS. Clinicopathologic features of biopsied lacrimal gland masses in 95 Korean patients. Graefes Arch Clin Exp Ophthalmol. 2019;257:1527–33.
Gounder P, Oliphant H, Juniat V, Koenig M, Selva D, Rajak SN. Histopathological features of asymmetric lacrimal gland enlargement in patients with thyroid eye disease. Thyroid Res. 2023;16:32.
Kilickesmez Ö, Tasdelen N, Gürses B, Akşit Z, Cihangiroglu M, Gurmen N. Primary MALT lymphoma of lacrimal gland in association with Sjögren syndrome: assessment with MR imaging. Yeditepe Med J. 2008;5:29–32.
Nocturne G, Mariette X. Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management. Br J Haematol. 2015;168:317–27.
Demirci H, Shields CL, Karatza EC, Shields JA. Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases. Ophthalmology. 2008;115:1626–.e1–3.